Date | Insider | Price | Amount |
---|---|---|---|
7-10-2023 Insider Buy |
Steven Gillis Director |
$1.65 CAGR » |
$1,004,998.50 609,090 shares |
12-3-2021 Insider Buy |
Nell Beattie Chief Business Officer |
$2.45 CAGR » |
$20,083.44 8,200 shares |
4-24-2020 Insider Buy |
PERCEPTIVE ADVISORS LLC >10% Owner |
$1.10 CAGR » |
$9,999,999.90 9,090,909 shares |
10-4-2019 Insider Buy |
Francisco Diaz-mitoma Chief Medical Officer |
$0.50 CAGR » |
$27,250.00 54,500 shares |
10-1-2019 Insider Buy |
Nell Beattie Chief Business Officer |
$0.48 CAGR » |
$4,822.00 10,000 shares |
10-1-2019 Insider Buy |
Christopher McNulty CFO and Head of BD |
$0.47 CAGR » |
$5,676.00 12,000 shares |
9-23-2019 Insider Buy |
PERCEPTIVE ADVISORS LLC >10% Owner |
$0.50 CAGR » |
$10,000,000.00 20,000,000 shares |
9-19-2019 Insider Buy |
Steven Gillis Director |
$0.50 CAGR » |
$5,000,000.00 10,000,000 shares |
6-27-2019 Insider Buy |
Francisco Diaz-mitoma Chief Medical Officer |
$1.07 CAGR » |
$8,560.00 8,000 shares |
6-18-2019 Insider Buy |
PERCEPTIVE ADVISORS LLC >10% Owner |
$0.65 CAGR » |
$650,000.00 1,000,000 shares |
6-19-2019 Insider Buy |
Jeff Baxter CEO, President |
$0.73 CAGR » |
$105,336.00 144,000 shares |
6-19-2019 Insider Buy |
Nell Beattie Chief Business Officer |
$0.74 CAGR » |
$5,885.60 8,000 shares |
6-17-2019 Insider Buy |
PERCEPTIVE ADVISORS LLC >10% Owner |
$0.62 CAGR » |
$618,000.00 1,000,000 shares |
12-17-2018 Insider Buy |
Tomer Kariv Director |
$1.40 CAGR » |
$1,999,999.40 1,428,571 shares |
12-13-2018 Insider Buy |
PERCEPTIVE ADVISORS LLC >10% Owner |
$1.40 CAGR » |
$19,999,999.60 14,285,714 shares |
8-6-2018 Insider Buy |
Jeff Baxter CEO, President |
$1.93 CAGR » |
$15,607.08 8,100 shares |
8-3-2018 Insider Buy |
Francisco Diaz-mitoma Chief Medical Officer |
$2.13 CAGR » |
$19,200.00 9,000 shares |
8-3-2018 Insider Buy |
Jeff Baxter CEO, President |
$2.01 CAGR » |
$27,110.70 13,500 shares |
8-3-2018 Insider Buy |
Nell Beattie Chief Business Officer |
$2.01 CAGR » |
$4,011.40 2,000 shares |
7-31-2018 Insider Buy |
Jeff Baxter CEO, President |
$2.28 CAGR » |
$38,236.80 16,800 shares |
5-24-2018 Insider Buy |
Jeff Baxter CEO, President |
$2.99 CAGR » |
$32,890.00 11,000 shares |
12-12-2017 Insider Buy |
Jeff Baxter CEO, President |
$3.89 CAGR » |
$38,853.91 10,000 shares |
11-28-2017 Insider Buy |
Jeff Baxter CEO, President |
$4.75 CAGR » |
$71,250.00 15,000 shares |
10-30-2017 Insider Buy |
Opko Health, Inc. >10% Owner |
$3.05 CAGR » |
$2,000,000.90 655,738 shares |
10-30-2017 Insider Buy |
Sam Chawla Director |
$3.05 CAGR » |
$9,455,000.00 3,100,000 shares |
10-30-2017 Insider Buy |
Steven Gillis Director |
$3.05 CAGR » |
$915,000.00 300,000 shares |
10-26-2017 Insider Buy |
PERCEPTIVE ADVISORS LLC >10% Owner |
$3.05 CAGR » |
$9,455,000.00 3,100,000 shares |
8-21-2017 Insider Buy |
Jeff Baxter CEO, President |
$3.22 CAGR » |
$32,200.00 10,000 shares |
8-21-2017 Insider Buy |
Francisco Diaz-mitoma Chief Medical Officer |
$3.17 CAGR » |
$9,510.00 3,000 shares |
8-10-2017 Insider Buy |
Jeff Baxter CEO, President |
$3.28 CAGR » |
$32,800.00 10,000 shares |
12-6-2016 Insider Buy |
PERCEPTIVE ADVISORS LLC >10% Owner |
$3.05 CAGR » |
$10,321,062.75 3,383,955 shares |
8-14-2015 Insider Buy |
PERCEPTIVE ADVISORS LLC >10% Owner |
$2.08 CAGR » |
$1,352,000.00 650,000 shares |
Also See: Institutional Holders of VBIV
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 07/11/2023 | |
End date: | 04/26/2024 | |
Start price/share: | $1.46 | |
End price/share: | $0.57 | |
Dividends collected/share: | $0.00 | |
Total return: | -60.96% | |
Annualized Gain: | -76.72% | |
Starting investment: | $10,000.00 | |
Ending investment: | $3,904.00 | |
Years: | 0.79 |
VBI Vaccines Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent VBI Vaccines insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding VBIV
Free VBIV Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |